Tech Company Financing Transactions
Notable Funding Round
On 7/17/2019, Notable announced $40 million in Series B investment from B Capital Group, Lifeforce Ventures and Industry Ventures.
Transaction Overview
Company Name
Announced On
7/17/2019
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series B
Investors
B Capital Group (Lead Investor) (Adam Seabrook)
Lifeforce Ventures (Lead Investor) (John Noonan)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
320 Hatch Dr.
Foster City, CA 94404
USA
Foster City, CA 94404
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Notable Labs is a translationally focused drug development company that uses a clinically validated, automated compound sensitivity platform to identify and advance novel therapeutic candidates to dramatically reduce the cost and time of the traditional drug development process.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Matthew Silva
Chief Executive Officer
Laurie Heilmann
Chief Medical Officer
Hiroomi Tada
Chief Scientific Officer
Joseph Wagner
Vice President
Marianne Santaguida
VP - Engineering
Scott Patterson
Browse more venture capital transactions:
Prev: 7/17/2019: Curve venture capital transaction
Next: 7/18/2019: TurboTenant venture capital transaction
Share this article
News on VC Transactions
We record every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs